Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation.
Sashida G, Harada H, Matsui H, Oshima M, Yui M, Harada Y, Tanaka S, Mochizuki-Kashio M, Wang C, Saraya A, Muto T, Hayashi Y, Suzuki K, Nakajima H, Inaba T, Koseki H, Huang G, Kitamura T, Iwama A.
Sashida G, et al. Among authors: harada h, harada y.
Nat Commun. 2014 Jun 23;5:4177. doi: 10.1038/ncomms5177.
Nat Commun. 2014.
PMID: 24953053
Free article.